Last Updated: May 6, 2026

PROPRANOLOL Drug Patent Profile

✉ Email this page to a colleague

« Back to Dashboard

When do Propranolol patents expire, and when can generic versions of Propranolol launch?

Propranolol is a drug marketed by Actavis Elizabeth, Adare Pharms Inc, Amta, Anda Repository, Extrovis, Inwood Labs, Lupin Ltd, Upsher Smith Labs, Zydus Pharms Usa Inc, Baxter Hlthcare Corp, Chartwell Injectable, Fosun Pharma, Fresenius Kabi Usa, Hikma Farmaceutica, Smith And Nephew, Solopak, Hikma, Pai Holdings Pharm, Aiping Pharm Inc, Ani Pharms, Chartwell Rx, Dava Pharms Inc, Duramed Pharms Barr, Impax Labs Inc, Innogenix, Interpharm, Ipca Labs Ltd, Ivax Sub Teva Pharms, Lederle, Mankind Pharma, Mylan, Northstar Hlthcare, Ph Health, Purepac Pharm, Roxane, Sandoz, Schering, Superpharm, Teva, Warner Chilcott, Watson Labs, Watson Labs Teva, and Rising. and is included in one hundred and thirty-eight NDAs.

The generic ingredient in PROPRANOLOL is hydrochlorothiazide; propranolol hydrochloride. There are thirty-two drug master file entries for this compound. Additional details are available on the hydrochlorothiazide; propranolol hydrochloride profile page.

AI Deep Research

Questions you can ask:

What is the 5 year forecast for PROPRANOLOL?
What are the global sales for PROPRANOLOL?
What is Average Wholesale Price for PROPRANOLOL?

Summary for PROPRANOLOL

US Patents:	0
Applicants:	43
NDAs:	138
Drug Prices:	Drug price information for PROPRANOLOL
Drug Sales Revenues:	Drug sales revenues for PROPRANOLOL
DailyMed Link:	PROPRANOLOL at DailyMed

Drug patent expirations by year for PROPRANOLOL

Drug Prices for PROPRANOLOL

US Patents and Regulatory Information for PROPRANOLOL

+ Get email alerts for changes to this table

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Impax Labs Inc	PROPRANOLOL HYDROCHLORIDE	propranolol hydrochloride	TABLET;ORAL	071976-002	May 13, 1986	AB	RX	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Mankind Pharma	PROPRANOLOL HYDROCHLORIDE	propranolol hydrochloride	TABLET;ORAL	216663-005	Jan 27, 2026	AB	RX	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Hikma Farmaceutica	PROPRANOLOL HYDROCHLORIDE	propranolol hydrochloride	INJECTABLE;INJECTION	077760-001	Jan 31, 2008	AP	RX	No	Yes	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Upsher Smith Labs	PROPRANOLOL HYDROCHLORIDE	propranolol hydrochloride	CAPSULE, EXTENDED RELEASE;ORAL	078311-004	Mar 6, 2009		DISCN	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Watson Labs	PROPRANOLOL HYDROCHLORIDE	propranolol hydrochloride	TABLET;ORAL	070551-001	Jul 10, 1986		DISCN	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Watson Labs	PROPRANOLOL HYDROCHLORIDE	propranolol hydrochloride	TABLET;ORAL	070142-001	Jul 30, 1985		DISCN	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.